About this trial
Transgender people can benefit from psychological, psychiatric, endocrinological support, sexual reassignment surgery, sexology support and dermatological care. The value of transitional care courses is scientifically recognized. Currently, the modalities of decision and realization of the care paths are heterogeneous on the territory, little standardized, and are the subject of debates between representatives of users and medical teams.
The french national report of IGAS from 2011 warns of the need to argue and legitimize care practices through more numerous, more exhaustive scientific studies, presenting a better level of evidence
Since 2011, no prospective study has been carried out on the national and international level, making it possible to assess the relevance of the planned care modalities. This research project, conducted over five consecutive years at the first contact of a transgender people with a care device, aims to correlate a variation in the quality of life of people with the characteristics of the care methods provided. This is a first proposal to assess care practices for transgender people. The results of this study would first allow us to infer the care modalities most suited to the needs of people. Secondly, secondary hypotheses could support new experimental protocols.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
With a diagnosis of Gender Dysphoria according to DSM5 diagnostic criteria
Wishing to benefit from supportive care for their transition trajectory and addressing a care system represented by the collaborating centers participating in the study,
Willing to comply with all study procedures and duration,
Understanding and able to speak French.
Disqualifiers
Minor or adult under curatorship, under judicial protection, persons deprived of their liberty
Refusal to participate after clear and fair information from the study
Person with sexual reassignment surgery or with cross hormon therapy since two years.
Trial population
transgender people in medical transition
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Quality of life scores
Scores on the WHOQOL BREF (World Health Organisation Quality Of Life) scale
Secondary outcomes
Social factors (age, gender, profession, knowledge of care system)
Answers given by the patient during interview
Satisfaction of the shared medical decision
Scores on the CDIS (Clinical Decision-making Involvement and Satisfaction) clinical decision making involvement and satisfaction score 15 questions scored 1-5 (totally disagree, strongly disagree, neither agree nor disagree, strongly agree, totally agree)
Satisfaction of body image
Score on the BIS (Body Image Scale), total score ranges from 0 to 30, A higher score means a higher level of body image disturbance
General psychopathology
French version of Mini International Neuropsychiatric Interview (DSM)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: